A Familiar Drug Can Keep Early-Stage HCM at Bay

August 29, 2021

People genetically predisposed to hypertrophic cardiomyopathy (HCM) could slow down their disease progression by taking an inexpensive, widely available medication, the VANISH trial suggested.

Read the full story here.